Aerosol propellants are categorized into varied types based on their functionalities, such as DME, HFC, HFO, other hydrocarbons, and others. Other hydrocarbons are advantageous in terms of low cost, stability & purity, wide range of vapour pressure, low toxicity, and environment friendly characteristics as compared to other propellants.
Europe is a global leader in the consumption of aerosol propellants and this dominance is expected to continue till 2020. Germany, France, and the U.K. are the key countries in this region, consuming more than 65% of the demand for aerosol propellants in Europe. The Asia-Pacific market is expected to grow at the highest CAGR from 2015 to 2020 owing to increase in total disposable income and changing lifestyle of consumers in this region.
Personal care and household are two major applications of the aerosol propellant market. In the personal care industry, propellants are utilized in the manufacturing of deodorants/antiperspirants, hair mousse, hairsprays, shaving mousse, gels, and other body care products. In the household industry, aerosol propellants are used in insecticides, textile/fabric care, air fresheners, furniture/waxes, oven cleaners, bathroom & kitchen cleaning mousse, and other products. The household application segment is expected to grow at the highest CAGR during the forecast period owing to increase in consumption of household products.
This study estimates the market value for aerosol propellant during the forecast period (2015 to 2020). As a part of quantitative analysis, the study segments the market by the different application of aerosol propellants at country level, with the current market estimation and forecast till 2020. Major countries covered in this report include China, Japan, India, Brazil, Germany, the U.K., France, Italy, Spain, Poland, Canada, Mexico, and the U.S. On the basis of type, the market is classified into DME, HFC, HFO, other hydrocarbons, and others. Similarly, by application this market is classified into personal care, household, medical, and others.
Further, as a part of qualitative analysis, the research provides a comprehensive review of major market drivers, restraints, opportunities, challenges, and regulations. It also discusses competitive strategies adopted by different market players, such as BOC (U.K.), Grillo-Werke AG (Germany), Honeywell International Inc. (U.S.), Royal Dutch Shell Plc (Netherlands), and Arkema Group (France). With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs.
The following customization options are available for the report: - Further breakdown of other Asia-Pacific & European markets - Company information - Detailed analysis and profiling of additional market players (Up to 3)
Reasons to buy this report: This report covers the following key aspects: - What will be the market size by 2020 and what will be the growth rate - What are the key market trends - What is driving this market - What are the challenges that impact market growth - Who are the key players in this market - Global report covers key regions such as North America, Europe, and Asia-Pacific with their major countries
Our reports have been used by over 10K customers, including:
The liposome drug delivery market is expected to reach US$ 6,992.95 million by 2027 from US$ 3,594.41 million in 2019. The market is estimated to grow at a CAGR of 8.8% from 2020 to 2027.
The growth of the market is attributed to a few key driving factors such as increasing prevalence of chronic diseases, growing demand for noninvasive...
Market Overview Global Smart Pills Drug Delivery market is expected to witness a CAGR of 11.50% during the forecast period. Certain factors that are driving the market growth include increasing preference for minimally invasive devices, increasing incidence of gastrointestinal disorders, and technological advancements. There...
Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular, Nasal/Buccal Drug Delivery Technologies, Biologics, Vaccines The Drug Delivery Technologies market is estimated to grow at a CAGR of 8.3% in the first half of the forecast period. The Oral Drug Delivery Technologies submarket held 50% of this market in 2018. How...
The transradial access devices market is estimated to grow at a CAGR of 7.5% during the forecast period The global transradial access devices market is expected to grow at a CAGR of 7.5% to reach to USD 2.18 billion by 2022 from an estimated USD 1.52 billion in 2017. The driving factors of this market are rising prevalence...
Summary Generex Biotechnology Corp (Generex) carries out the research, development and commercialization of drug delivery systems and technologies. The company focuses on drug delivery system of large molecules in the areas of seasonal influenza virus, melanoma, ovarian cancer, HIV, HPV, allergy and Type I diabetes mellitus....
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.